PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignanciesYonghui Sun, Yu Rao, Xingwang Zhao et al.|Cell Research|2018Cited by 280
A chemical approach for global protein knockdown from mice to non-human primatesXiuyun Sun, Yu Rao, Xinyi Zhang et al.|Cell Discovery|2019Cited by 115
Global PROTAC Toolbox for Degrading BCR–ABL Overcomes Drug-Resistant Mutants and Adverse EffectsYiqing Yang, Yu Rao, Hongying Gao et al.|Journal of Medicinal Chemistry|2020Cited by 91
Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACsHongying Gao, Yu Rao, Yue Wu et al.|ACS Medicinal Chemistry Letters|2019Cited by 85
Merging PROTAC and molecular glue for degrading BTK and GSPT1 proteins concurrentlyZimo Yang, Yu Rao, Yonghui Sun et al.|Cell Research|2021Cited by 76